(Q48607322)

English

The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons

scientific article published on December 17, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons (English)

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

heterocyclic bridged bicyclo compounds

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797560

28 November 2022

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

author name string

Y. Minabe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797560

28 November 2022

C. R. Ashby

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797560

28 November 2022

R. Y. Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797560

28 November 2022

language of work or name

0 references

publication date

1 December 1991

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

17 December 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1797560

28 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:001429999190163K?httpAccept=text/xml

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

https://api.elsevier.com/content/article/PII:001429999190163K?httpAccept=text/plain

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

209

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

151-156

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

Does treatment with haloperidol for 3 weeks produce depolarization block in midbrain dopamine neurons of unanaesthetized rats?

1

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Differential effect of typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medical prefrontal cortical cells: a microiontophoretic study

2

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons

3

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat

4

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

6

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

8

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

12

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.

13

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.

14

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons

15

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons

16

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

17

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

18

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

19

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species

20

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding

21

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Electrochemistry in vivo: application to CNS pharmacology

22

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

23

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons

24

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells

25

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

26

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

An anatomy of schizophrenia?

27

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

29

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

30

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.

31

1 reference

10.1016/0014-2999(91)90163-K

https://api.crossref.org/works/10.1016/0014-2999(91)90163-K

28 November 2022

Identifiers

10.1016/0014-2999(91)90163-K

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/1797560

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48607322&oldid=1780282611"